JavaScript is disabled in your browser. You can still read and search, but features like search previews, menus, and forms may not work until it's enabled.

Functional Unblinding in Pivotal Studies and the Future of Psychedelic Medicine.

J Clin Psychiatry August 21, 2024 DOI: 10.4088/jcp.24com15504 (opens in new tab)

Relevant Not relevant

Study at a glance

AI-extracted from the abstract

Characteristics	Theoretical or philosophical paper Peer reviewed
Key points	Argues that functional unblinding compromises the validity of psychedelic clinical trials and that new methodological approaches are needed to ensure reliable results.

Abstract

Functional Unblinding in Pivotal Studies and the Future of Psychedelic Medicine.

Causal Inference in Studies with Functional Unmasking: Psychedelics and Beyond medRxiv Preprint Server December 5, 2025
Who is blind in psychedelic research? Letter to the editor regarding: blinding and expectancy confounds in psychedelic randomized controlled trials Expert Review of Clinical Pharmacology July 6, 2021
Commentary on Methods for Addressing Functional Unblinding and Mechanistic Uncertainty in Clinical Trials of Psychedelic-Assisted Treatments Current Treatment Options in Psychiatry November 11, 2025 2 citations
Blinding Integrity in Psychedelic Randomized Clinical Trials JAMA Psychiatry April 15, 2026 4 citations
Blinding integrity in psychedelic research: Evidence from a comparative randomized controlled trial of psilocybin, MDMA, and methylphenidate in healthy volunteers. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology May 28, 2026